Thromboembolism: all 818 studies
Page 6 of 9. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Verification of XAPPORT: a Decision Support App for Physicians Used for Patients Anticoagulated With Rivaroxaban in Terms of Anticoagulation Management in Elective Surgery: Verification Process of Medical Decision AlgorithmWithdrawnNCT02900404
- Development and Validation of Automated Indicators on the Appropriateness of Oral Anticoagulant PrescriptionsCompletedNCT02898090
- Incidence of Venous Thromboembolism and Professional Practices in Brest AreaCompletedNCT02895971
- Anticoagulation Medical HomeCompletedNCT02870296Not applicable
- Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in ThromboembolismCompletedNCT02864810Phase 1
- Self-management of Anticoagulation TreatmentCompletedNCT02864537Not applicable
- anti10a Levels in Women Treated With LMWH in the Postpartum PeriodCompletedNCT02856295Phase 4
- Measure of Plasma Tissue Factor to Predict a Venous Thromboembolism in Primitive Cancer of LungCompletedNCT02853188Not applicable
- ELIQUIS (APIXABAN) Regulatory Post-Marketing Surveillance In Clinical Practice for Venous Thromboembolism (VTE) Treatment and Prevention Of Recurrent VTECompletedNCT02836457
- Direct Oral Anticoagulants and Venous ThromboembolismCompletedNCT02833987
- PK of Rivaroxaban in Bariatric Patients - ExtensionCompletedNCT02832947Phase 1
- RIVET - Retrospective Cohort Study on the Risk of Venous ThromboembolismCompletedNCT02828904
- Prospective and Monocentric Study of the Incidence of Venous Thromboembolic Disease (VTE) in Spinal Cord Injury (SCI) Patient Between 3 and 12 Months After SCITerminatedNCT02796235Not applicable
- Bemiparin Versus Enoxaparin in the Prevention of Venous Thromboembolism Among ICU PatientsCompletedNCT02795065Not applicable
- Cancer-related Thromboembolic DiseaseStatus unknownNCT02785757Not applicable
- Assessment of a Diagnostic Medical Device for the INR (International Normalized Ratio) MeasurementCompletedNCT02779400Not applicable
- Patient-Centered Anticoagulation Self-Monitoring in Minority PatientsCompletedNCT02776566Not applicable
- Cancer Associated Thrombosis, a Pilot Treatment Study Using RivaroxabanCompletedNCT02746185Phase 3
- A Non-interventional Study on Xarelto for Treatment of Venous Thromboembolism (VTE) and Prevention of Recurrent VTE in Patients With Active CancerCompletedNCT02742623
- Tumor-educated Platelets in Venous ThromboembolismCompletedNCT02739867
- Detecting Circulating Emboli in Patients with Acute Venous ThromboembolismWithdrawnNCT02735759Not applicable
- IgG Dependent Monocyte Activation in Proximal Venous ThromboembolismCompletedNCT02713581
- Effect of Intravenous Continuous Infusion Heparin on Rates of Venous Thromboembolism in High-Risk, Critically Ill PatientsWithdrawnNCT02707263Not applicable
- Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin DoseCompletedNCT02704052Early Phase 1
- Radiation Impact on Thromboembolic EventsCompletedNCT02696447
- Twice Daily Enoxaparin Prophylaxis in Reconstructive Surgery PatientsCompletedNCT02687204Phase 1
- StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot StudyStatus unknownNCT02679664Phase 2
- A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter SystemCompletedNCT02674672Not applicable
- Venous Thromboembolism in Renally Impaired Patients and Direct Oral AnticoagulantsTerminatedNCT02664155Phase 3
- Description of Patients With Acute Venous Thromboembolism in the UK's Clinical Practice Research Datalink Linked With Hospital Episode Statistics Dataset (CPRD-HES)CompletedNCT02661568
- Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.Status unknownNCT02597218
- Rivaroxaban in Endovenous Laser Ablation With and Without MiniphlebectomyCompletedNCT02584842
- Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer PatientsTerminatedNCT02583191Phase 3
- REVIparin-BRIDging-in a General Practice Setting in GErmanyTerminatedNCT02579122
- Special Drug Use Investigation of Xarelto for Venous Thromboembolism (VTE)CompletedNCT02558465
- The Clinical Application of Infrared Thermal Imaging Detecting Venous ThromboembolismCompletedNCT02552420
- Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMSCompletedNCT02546817
- Tecarfarin Anti-Coagulation Trial (TACT)Status unknownNCT02522221Phase 3
- Tumescent Antibiotic Delivery for Prevention of Surgical Site InfectionStatus unknownNCT02503904Phase 2/3
- Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer CenterCompletedNCT02502396
- Pilot Feasibility and Safety of Administering Weight Adjusted Fixed LMWH DoseStatus unknownNCT02486666Phase 3
- Venous Thromboembolic Complications in Ovarian CancerStatus unknownNCT02480790
- Observational Study of Thrombogenic Properties in 220 Patients With Proximal Femur FractureTerminatedNCT02475187
- : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft SurgeryCompletedNCT02474212Phase 4
- Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation PatientsCompletedNCT02461602
- Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®CompletedNCT02444572Phase 4
- Haemorrhages and Thromboembolic Venous Disease of the PostpartumCompletedNCT02443610
- Rivaroxaban in Bariatric SurgeryCompletedNCT02438098Phase 1
- Evaluation of the Short and Long Term Performance and Clinical Outcomes of the Crux Vena Cava Filter SystemWithdrawnNCT02420626
- Role of Femoral Nerve Block on Prevention of Postoperative Deep Venous ThromboembolismStatus unknownNCT02411097Not applicable
- Venous Thromboembolism and Bleeding in Hospitalized Medical Patients With CancerCompletedNCT02407717
- The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - StudyCompletedNCT02379806Phase 3
- The Effect of Medication Timing on Anticoagulation Stability in Users of Warfarin: The "INRange" RCTCompletedNCT02376803Phase 4
- Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic SurgeryCompletedNCT02334007Phase 1/2
- An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major BleedingCompletedNCT02319460
- Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic RiskStatus unknownNCT02313584Phase 3
- Apixaban for Secondary Prevention of Thromboembolism Among Patients With AntiphosPholipid SyndromeCompletedNCT02295475Phase 4
- Prophylaxis of Venous Thromboembolism After Bariatric SurgeryStatus unknownNCT02295150Phase 4
- Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee ArthroplastyCompletedNCT02271399Phase 2
- Long Term Outcomes of Venous ThromboembolismStatus unknownNCT02268630
- Follow-up in Rivaroxaban Patients in Setting of ThromboembolismCompletedNCT02248610
- CT for Pulmonary Thromboembolic DiseaseTerminatedNCT02241525
- A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill PatientsCompletedNCT02213978
- Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care TherapyCompletedNCT02210819
- Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral AnticoagulantsCompletedNCT02185027
- Pharmacokinetic (PK) Assessment of BIBR 1048 in Patients After Primary Elective Total Hip Replacement SurgeryCompletedNCT02170935Phase 2
- BIBR 1048 in the Prevention of Venous Thromboembolism in Patients Undergoing Primary Elective Total Hip Replacement SurgeryCompletedNCT02170701Phase 2
- Using a Novel Algorithm to Improve the Retrieval Rate of Inferior Vena Cava Filters (iRetrieve Study)Status unknownNCT02160964
- Global Anticoagulant Registry in the FIELD- Venous Thromboembolic EventsCompletedNCT02155491
- Influence of ABCB1 Polymorphisms on Plasma Concentrations of New Oral Anticoagulants in Case of Serious Adverse EventsCompletedNCT02103101Not applicable
- Pharmacokinetics of Enoxaparin in Intensive Care PatientsCompletedNCT02095509Phase 4
- Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator ImplantationTerminatedNCT02094157Phase 3
- Outpatient Treatment of Low-Risk Venous Thromboembolism With Target Specific AnticoagulantCompletedNCT02079584
- Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial FibrillationCompletedNCT02067182Phase 4
- Single Session Percutaneous Mechanical Thrombectomy for the Treatment of Ilio-femoral Deep Vein Thrombosis: A Preliminary EvaluationTerminatedNCT02066597Phase 2
- Apixaban for the Prevention of Venous Thromboembolism in Cancer PatientsCompletedNCT02048865Phase 2
- Pneumatic Compression for Preventing Venous ThromboembolismCompletedNCT02040103Not applicable
- Effectiveness And Safety of LMWH Treatment in Cancer Patients Diagnosed With Non-High Risk Venous ThromboembolismStatus unknownNCT02017743
- Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With CancerCompletedNCT01989845Phase 4
- Multicenter Registry for Effectiveness Analysis of ActiveCare+S.F.T® Mobile Compression Device for Thrombosis Prevention in Hip and Knee ArthroplastyCompletedNCT01984190
- Prophylaxis of Venous Thromboembolism in Advanced Lung CancerStatus unknownNCT01980849Phase 3
- Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction ModelCompletedNCT01972243
- Venous Thromboembolism Prophylaxis in a Tertiary UAE Hospital: Comparison of Clinical Practice Guidelines.CompletedNCT01958203
- Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial FibrillationCompletedNCT01938248Phase 4
- Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention StudyCompletedNCT01935414Not applicable
- Weight Based Enoxaparin in Trauma PatientsStatus unknownNCT01916707Phase 4
- Multicenter Registry for Comparative Effectiveness Analysis of Venous Thromboembolism in Trauma PatientsWithdrawnNCT01890044
- PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous ThromboembolismCompletedNCT01855698
- Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University HospitalCompletedNCT01851239
- Feasibility Study of Geko vs. IPCs in TraumaCompletedNCT01835990Phase 2
- Anticoagulation Length in Cancer Associated ThrombosisTerminatedNCT01817257Phase 2
- Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study ProgrammeCompletedNCT01809015
- Prescription and Utilization of Low Molecular Weight Heparin in Usual Medical Practice for the Curative Treatment of Venous Thromboembolism in Patients With CancerCompletedNCT01803022
- Study on the Clinical Course Of Pulmonary EmbolismCompletedNCT01781858
- Management and Detection of Atrial Tachyarrhythmias in Patients Implanted With BIOTRONIK DX SystemsCompletedNCT01774357
- Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of AgeWithdrawnNCT01773174Phase 2
- Anticoagulation With Rivaroxaban in Cardioversion -The ARC StudyCompletedNCT01747746Phase 4
- Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill PatientsCompletedNCT01744431
- Thromboprophylaxis of Venous Thromboembolism in Acutely-ill Medical Inpatients With ThrombocytopeniaTerminatedNCT01727401Phase 4
- Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee ArthroplastyCompletedNCT01720108Phase 3